bioAffinity Technologies

(NASDAQ) BIAF

Current Price$2.76

Market Cap$9.94M

Since IPO (2022)-99%

5 YearN/A

1 Year-85%

1 Month-45%

bioAffinity Technologies Financials at a Glance

Market Cap

$9.94M

Revenue (TTM)

$6.16M

Net Income (TTM)

$14.91M

EPS (TTM)

$-15.41

P/E Ratio

-0.14

Dividend

$0.00

Beta (Volatility)

1.57 (High)

Dividend

$0.00

Beta (Volatility)

1.57 (High)

Price

$2.76

Volume

1,811,192.343

Open

$2.31

Price

$2.76

Volume

1,811,192.343

Open

$2.31

Previous Close

$2.21

Daily Range

$2.17 - $2.80

52-Week Range

$0.69 - $15.00

Dividend

$0.00

Beta (Volatility)

1.57 (High)

Price

$2.76

Volume

1,811,192.343

Open

$2.31

Previous Close

$2.21

Daily Range

$2.17 - $2.80

52-Week Range

$0.69 - $15.00

BIAF News

bioAffinity Misses Q2 Revenue Target

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About bioAffinity Technologies

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Maria Zannes

Website

www.bioaffinitytech.com

Headquarters

San Antonio, TX 78257, US

BIAF Financials

Key Financial Metrics (TTM)

Gross Margin

23%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-302%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-7.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.94M

Shares Outstanding

4.50M

Volume

1.81M

Avg. Volume

8.72M

Financials (TTM)

Gross Profit

$1.43M

Operating Income

$10.57M

EBITDA

$10.07M

Operating Cash Flow

$9.33M

Capital Expenditure

$60.57K

Free Cash Flow

$9.39M

Cash & ST Invst.

$6.45M

Total Debt

$1.16M

bioAffinity Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.59M

-27.8%

Gross Profit

$301.21K

-38.8%

Gross Margin

18.91%

N/A

Market Cap

$9.94M

N/A

Market Cap/Employee

$174.42K

N/A

Employees

N/A

Net Income

$3.14M

-5.7%

EBITDA

$3.01M

-8.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$5.29M

+1435.9%

Accounts Receivable

$541.96K

-52.4%

Inventory

$53.55K

+94.0%

Long Term Debt

$776.95K

-3.7%

Short Term Debt

$383.87K

-44.7%

Return on Assets

-1.36%

N/A

Return on Invested Capital

-1.31%

N/A

Free Cash Flow

$2.50M

-49.0%

Operating Cash Flow

$2.56M

-52.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ARTLArtelo Biosciences, Inc.

ARTLArtelo Biosciences, Inc.$3.43-9.02%

SLRXSalarius Pharmaceuticals, Inc.

SLRXSalarius Pharmaceuticals, Inc.$0.84+29.23%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.15+0.00%

GTBPGT Biopharma, Inc.

GTBPGT Biopharma, Inc.$0.27-3.50%

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.95-0.00%

MNDRMobile-health Network Solutions Class A Ordinary Shares

MNDRMobile-health Network Solutions Class A Ordinary Shares$0.76-6.67%

LIPOLipella Pharmaceuticals Inc.

LIPOLipella Pharmaceuticals Inc.$0.08+54.68%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$11.03+0.03%

POETPoet Technologies

POETPoet Technologies$7.78-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.08-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$59.88-0.04%

BBBYBeyond, Inc.

BBBYBeyond, Inc.$5.13-0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$54.81+0.04%

PFEPfizer

PFEPfizer$26.73-0.00%

Questions About BIAF

What is the current price of bioAffinity Technologies?

bioAffinity Technologies is trading at $2.73 per share.

What is the 52-week range for bioAffinity Technologies?

Over the past 52 weeks, bioAffinity Technologies has traded between $0.69 and $15.00.

How much debt does bioAffinity Technologies have?

As of the most recent reporting period, bioAffinity Technologies reported total debt of $1.16M.

How much cash does bioAffinity Technologies have on hand?

bioAffinity Technologies reported $6.45M in cash and cash equivalents in its most recent financial results.

What is bioAffinity Technologies’s dividend yield?

bioAffinity Technologies does not currently have a dividend yield.

bioAffinity Technologies

bioAffinity Technologies Financials at a Glance

BIAF News

bioAffinity Misses Q2 Revenue Target

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About bioAffinity Technologies

BIAF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

bioAffinity Technologies Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIAF

What is the current price of bioAffinity Technologies?

What is the 52-week range for bioAffinity Technologies?

How much debt does bioAffinity Technologies have?

How much cash does bioAffinity Technologies have on hand?

What is bioAffinity Technologies’s dividend yield?

Premium Investing Services